Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC GLENMARK PHARMA ALEMBIC/
GLENMARK PHARMA
 
P/E (TTM) x 28.2 -31.3 - View Chart
P/BV x 1.0 2.8 36.3% View Chart
Dividend Yield % 2.6 0.3 1,003.4%  

Financials

 ALEMBIC   GLENMARK PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-23
GLENMARK PHARMA
Mar-23
ALEMBIC/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs87487 17.9%   
Low Rs56349 15.9%   
Sales per share (Unadj.) Rs5.0460.4 1.1%  
Earnings per share (Unadj.) Rs3.113.4 23.5%  
Cash flow per share (Unadj.) Rs3.435.0 9.7%  
Dividends per share (Unadj.) Rs2.202.50 88.0%  
Avg Dividend yield %3.10.6 516.2%  
Book value per share (Unadj.) Rs80.9335.1 24.1%  
Shares outstanding (eoy) m256.78282.17 91.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.40.9 1,583.7%   
Avg P/E ratio x22.731.3 72.6%  
P/CF ratio (eoy) x21.011.9 175.6%  
Price / Book Value ratio x0.91.2 70.6%  
Dividend payout %70.118.7 374.9%   
Avg Mkt Cap Rs m18,298117,953 15.5%   
No. of employees `000NANA-   
Total wages/salary Rs m24027,810 0.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,272129,901 1.0%  
Other income Rs m6433,168 20.3%   
Total revenues Rs m1,915133,069 1.4%   
Gross profit Rs m29715,125 2.0%  
Depreciation Rs m676,113 1.1%   
Interest Rs m53,496 0.1%   
Profit before tax Rs m8688,685 10.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624,911 1.3%   
Profit after tax Rs m8063,774 21.4%  
Gross profit margin %23.411.6 200.6%  
Effective tax rate %7.156.5 12.6%   
Net profit margin %63.42.9 2,180.8%  
BALANCE SHEET DATA
Current assets Rs m1,72198,737 1.7%   
Current liabilities Rs m83850,455 1.7%   
Net working cap to sales %69.437.2 186.8%  
Current ratio x2.12.0 105.0%  
Inventory Days Days5,0387 75,214.5%  
Debtors Days Days673115 584.1%  
Net fixed assets Rs m20,32476,920 26.4%   
Share capital Rs m514282 182.0%   
"Free" reserves Rs m20,26794,281 21.5%   
Net worth Rs m20,78094,563 22.0%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m22,046175,658 12.6%  
Interest coverage x187.73.5 5,386.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.10.7 7.8%   
Return on assets %3.74.1 88.9%  
Return on equity %3.94.0 97.2%  
Return on capital %4.29.2 45.9%  
Exports to sales %1.20-   
Imports to sales %2.40-   
Exports (fob) Rs m16NA-   
Imports (cif) Rs m30NA-   
Fx inflow Rs m1646,464 0.0%   
Fx outflow Rs m3012,712 0.2%   
Net fx Rs m-1433,751 -0.0%   
CASH FLOW
From Operations Rs m3896,254 6.2%  
From Investments Rs m73-5,285 -1.4%  
From Financial Activity Rs m-464-775 59.9%  
Net Cashflow Rs m-2325 -0.7%  

Share Holding

Indian Promoters % 70.9 46.7 151.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.9 34.7 2.7%  
FIIs % 0.9 23.7 3.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 53.4 54.6%  
Shareholders   94,012 209,931 44.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Glenmark Pharma Share Price Performance

Period ALEMBIC Glenmark Pharma S&P BSE HEALTHCARE
1-Day 4.45% -0.84% 1.18%
1-Month -14.38% 4.88% -0.75%
1-Year 48.89% 112.38% 61.82%
3-Year CAGR -6.22% 27.39% 18.16%
5-Year CAGR 14.99% 8.00% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 2.2 per share. This amounted to a Dividend Payout ratio of 70.1%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.